- Highly efficient cash conversion (101% FCF/OCF ratio)
- Pays a regular dividend of $0.80 per share
- Established player in the Healthcare sector
Prime Medicine, Inc. stock price took a fall of -7.01% on Monday
(Updated on Jul 13, 2026)
The Prime Medicine, Inc. stock price fell by -7.01% on the last day (Monday, 13th Jul 2026) from $3.78 to $3.52. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 4.86% from a day low at $3.50 to a day high of $3.67. The price has fallen in 5 of the last 10 days but is still up by 2.48% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -3 million shares and in total, 4 million shares were bought and sold for approximately $12.45 million.
The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Prime Medicine, Inc. stock with a 90% probability to be traded between $2.68 and $4.60 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
PRME Signals & Forecast
The Prime Medicine, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $4.00. On a fall, the stock will find some support from the long-term average at approximately $3.35. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, July 08, 2026, and so far it has fallen -23.92%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Prime Medicine, Inc. stock
Prime Medicine, Inc. finds support from accumulated volume at $3.43 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.170 between high and low, or 4.86%. For the last week, the stock has had daily average volatility of 11.33%.
Our recommended stop-loss: $3.31 (-5.96%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 3 days ago.)
Trading Expectations (PRME) For The Upcoming Trading Day Of Tuesday 14th
For the upcoming trading day on Tuesday, 14th we expect Prime Medicine, Inc. to open at $3.56, and during the day (based on 14 day Average True Range), to move between $3.33 and $3.70, which gives a possible trading interval of +/-$0.374 (+/-11.24%) up or down from last closing price. If Prime Medicine, Inc. takes out the full calculated possible swing range there will be an estimated 11.24% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $3.43 (2.42%) than the resistance at $3.78 (7.54%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Prime Medicine, Inc. stock A Buy?
Prime Medicine, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.
Current score:
0.516
Hold/Accumulate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on July 14, 2026 - $3.56 ( 1.23%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
PRME Performance
Trading levels for PRME
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 3.73 | 6.07% |
| R2 | 3.66 | 4.22% |
| R1 | 3.62 | 3.08% |
| Price | 3.52 | |
| S1 | 3.49 | -0.615% |
| S2 | 3.45 | -1.76% |
| S3 | 3.39 | -3.60% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 3.99 | 13.51% |
| R2 | 3.87 | 10.10% |
| R1 | 3.78 | 7.54% |
| Price | 3.52 | |
| S1 | 3.43 | -2.42% |
| S2 | 3.30 | -6.12% |
| S3 | 3.24 | -7.82% |
PRME Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Sep 10, 2019 | Sep 10, 2019 | Sep 10, 2019 | $0.80 | 0% |
| 2 | Jun 14, 2019 | Jun 14, 2019 | Jun 14, 2019 | $0.200 | 0% |
| 3 | Dec 18, 2018 | Dec 18, 2018 | Dec 18, 2018 | $0.213 | 0% |
| 4 | Sep 14, 2018 | Sep 14, 2018 | Sep 14, 2018 | $0.233 | 0% |
| 5 | Jun 21, 2018 | Jun 21, 2018 | Jun 21, 2018 | $0.146 | 0% |
FAQ
Click here for our free guide on how to buy Prime Medicine, Inc. Stock.
Buy PRME
A buy signal from a double bottom formation was found on Wednesday, June 10, 2026 and based on theory for this formation the price should go up by 21.42% to $4.27 within 15 trading days (Thursday, July 02, 2026) since signal was issued.